Core Scientific Inc. (CORZ) Dividend Safety Gauge & 10-Year DRIP Compounder

$12.51 -5.62% NASDAQ β€’ Live Quote vs Prior Daily Close (Synced Snapshot) EXT / AFTER-HRS: $12.36

Core Scientific Inc. (CORZ) carries a Roarable Rating of E (Strong Sell) with 25/100 RQD Confidence due to weak cash-flow efficiency and sensitivity to current interest rates. Wait for business cash flow and institutional buying to improve before committing fresh capital.

ROARABLE E β€’ RED ALERT Cap $4.26B
πŸ“€ Share Live RQD Speedometer Card: 𝕏 Post Reddit StockTwits ⬇ Live SVG Card
⚑ INSTANT AI QUANT PREVIEW β€’ $0 FREE TIER Click Any Pre-Computed AI Quant Specialist Briefing on CORZ Below β€” or Connect Your Own ChatGPT / Claude
πŸ€– Mara Quenwick β€’ AI Quant Lead (Click for Instant Brief) Is CORZ stock a Buy, Hold, or Sell right now according to Roarable's RQD model?
β–Ό

As of 2026-11-03, Core Scientific Inc. (NASDAQ: CORZ) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 25/100 at a spot price of $12.51 (-5.62% 1D, market cap $4.26B). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 3/20, and SEC Balance-Sheet Forensics 5/20. Across 1096 tracked Financials issuers, CORZ ranks #1057 in composite RQD confidence.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Ellis Vennor β€’ AI Peer & Flow Quant (Click for Instant Brief) How does CORZ compare to ENVA and NNI in the Financials sector?
β–Ό

Within the Financials sector (Finance: Consumer Services), CORZ carries a Roarable E (25/100 RQD), trailing P/E of N/A, gross margin of β€”, and ROIC of -35.0%. By comparison, ENVA (Enova International Inc.) holds a C- grade (61/100 RQD, P/E 14.4x, ROIC 17.1%, cap $4.26B) and NNI (Nelnet Inc.) posts a D+ grade (53/100 RQD, P/E 10.3x, ROIC 11.6%, cap $4.38B). Among the 5-stock peer group, NNI leads on earnings multiple (10.3x) while DAVE leads on capital efficiency (55.3% ROIC).

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– Gideon Ashmere β€’ AI SEC 10-K Forensics (Click for Instant Brief) What are the biggest fundamental strengths and SEC risk factors for CORZ?
β–Ό

Per CORZ's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001839341), Core Scientific Inc. generated $319.0M in revenue (-37.5% YoY), -$288.6M in net income, and -$450.8M in free cash flow against $2.35B in total assets and $1.06B in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

βœ“ Pre-computed one-to-many AI Quant brief
πŸ€– AI Quant Disclosure: Roarable Analysts are proprietary AI Quant Specialists β€” not human financial advisors. Pre-computed one-to-many briefings above are free; interactive 1-on-1 Q&A, custom AI sifting/indicator alerts, and personal ChatGPT/Claude MCP connections require a $9.95/mo Pro account (currently waitlist-only).
INTERACTIVE SCENARIO DECK:
πŸ›‘οΈ Portfolio Crash X-Ray
EXT / AFTER-HRS: $12.36 (-1.20%)🧬 Dilution Drag (+1.92% YoY Shares)βš™οΈ Cash Engine: 4/20 (E) β€’ 0% FCF Margin
Verify 90D Bucket Audit β†’
πŸ“Š Historical Track Record Warning: Scores below 50 (25/100 Β· E) historically underperformed SPY in 71% of rolling 90-day windows (-10.7% avg 90D alpha vs SPY β€’ 29.0% hit rate).
Audit Bucket Track Record β†’
RQD QUANT TACHOMETERRED ALERT β€’ E
025507510025
3-of-3 JEV AI Jury Bearish Warning
Cash
SEC
Whale

Impersonal quantitative research (0–100 RQD rubric) β€” not individualized investment advice. Past performance does not guarantee future results. Full Disclaimer

5-PILLAR SNOWFLAKE RADARRw E Β· Rk E
Cash (4)Whales (5)SEC (8)Macro (3)CEO (5)
Each axis scored 0–20
12M PRICE TARGET CONE-14.9% Base Target
$32 Bull$11 Base$8 Bear
πŸ“¬ FREE CORZ RATING-CHANGE & BRIEFING ALERTSManage / Unsubscribe
WHALE OPTIONS SNAPSHOT: β€” (No Active Options Snapshot on file for CORZ)Realized 20D OHLCV Swing Band: Β±12.5%
Deterministic 5-Pillar Attribution (25/100 Composite)
πŸ” WHY CORZ SCORES 25/100 (E) β€” TOP 3 DRIVERS2 Bullish Pillars + #1 Risk Drag
β–² #1 Bullish Driver: SEC 10-K Forensic Risk+8/20 pts (32% of score)

Altman Z-Score 3.80 (FORTRESS SAFE (>3.0)) β€’ Piotroski F-Score 5/9

β–² #2 Bullish Driver: Whale & Options Positioning+5/20 pts (20% of score)

20D Institutional Volume Accumulation (Β±12.5% realized swing band)

β–Ό #1 Drag / Risk Factor: Macro Regime Fit4/20 pts (-16 pt drag)

Macro rate sensitivity & RSI-14 (40.8) create a -16 pt regime headwind

πŸ“ˆ PAST 4 QUARTERS RQD vs SUBSEQUENT RETURNQ1 β†’ Q2 β†’ Q3 β†’ Current
Q1 (-3Q)
33
Grade E$13.51+5.5% Next Q
Q2 (-2Q)
30
Grade E$14.25+5.3% Next Q
Q3 (-1Q)
28
Grade E$15.00-16.6% Next Q
Current
25
Grade E$12.51-10.7% Hist 90D Ξ±
Trajectory: E (33) β†’ E (25)Full Audit β†’
βš”οΈ ADVERSARIAL OPPOSING CASE & FORENSIC KILL-SWITCH (WHY THE BULL/BEAR THESIS COULD FAIL)CONTRARIAN TURNAROUND & SHORT-SQUEEZE DOSSIER

βš”οΈ Adversarial Opposing Case: What Could Spark a CORZ Turnaround Squeeze

Gideon Ashmere Forensic Desk β†’

While CORZ currently carries a cautious 25/100 (E) rating due to Macro Regime Fit (4/20), shorts face asymmetric squeeze risk if free cash flow inflects or management executes accretive buybacks.

πŸš€ Contrarian Squeeze Trigger #1

Established market leader in Financials with deep daily trading liquidity.

πŸš€ Contrarian Squeeze Trigger #2

Options & Short-Covering Gamma: Reclaiming the 50-day SMA ($15.97) and Max Pain ($13.14) forces dealer call-delta covering toward $31.98.

πŸš€ Contrarian Squeeze Trigger #3

Forensic Repair Trigger: Halting share dilution (Dilution Drag (+1.92% YoY Shares)) or retiring high-cost debt immediately upgrades the SEC 10-K Forensic pillar.

🎲 LIVE PREDICTION MARKET ODDS TIED TO $CORZβ€’ $2.4M Crowd Pool β€’ Kalshi / Polymarket Composite
Contract: β€œCORZ Beats Next Quarter EPS Consensus (Dec 30, 2026) & Holds Above 200D SMA”
CASH DIVIDEND + BUYBACK YIELD
0.6% Total Yield
0% Cash ($0.00/yr) + 0.6% Buybacks
PAYOUT SAFETY SPEEDOMETER
74/100 β€’ REINVESTING IN GROWTH + BUYBACKS
FREE CASH FLOW PAYOUT RATIO
0% (100% Reinvested)
Retains cash flow for R&D and share repurchases
INTERACTIVE DRIP & SHAREHOLDER-YIELD COMPOUNDER (5.5% EST. ANNUAL)

$10,000 Compounded Over 10 Years β†’ $17,081

Est. Year-10 Shareholder Yield: $102/yr
$10.6K
Yr 1
$11.1K
Yr 2
$11.7K
Yr 3
$12.4K
Yr 4
$13.1K
Yr 5
$13.8K
Yr 6
$14.5K
Yr 7
$15.3K
Yr 8
$16.2K
Yr 9
$17.1K
Yr 10
ON-DEMAND RQD QUANT WORKSHOP β€’ SPONSORED / PARTNER SPOTLIGHTHosted by Perry Belcher & Roarable Forensic Quant Desk

Red-Light Warning Desk: Spotting SEC Cash-Flow & Dilution Risks Before Downgrades (Featuring CORZ)

  • βœ“Walkthrough of CORZ's RQD Radar, SEC cash-conversion gap & downside invalidation levels
  • βœ“3 asymmetric Bear/Hedge frameworks when 10-year Treasury yields stay elevated
  • βœ“Includes nightly RQD rating-change & forensic signal email alerts on your tracked stocks
RQD INSIDER CLUB WAITLIST$49/YR PLANNED
Want Custom AI PineScript / Python Indicators & Priority Rating-Change Alerts?
CORZ // CANDLESTICK & AUTO-TRENDLINE WORKSTATION6M: -40.71%πŸ›‘οΈ HOLDING TREND SUPPORT
2026-11-03O $14.43H $14.43L $12.51C $12.51VOL 18.92M
RES: $15.41SUP: $10.82SMA50: $15.97SMA200: $19.59
$31.73$26.47$21.20$15.94$10.68RES $15.41SUP $10.82$12.512026-05-042026-06-182026-08-052026-09-212026-11-03
PRIMARY-SOURCE FORENSICS, SECOND-ORDER LINKS & AI ANALYST DESK

CORZ Dilution Monitor, Expectations Hurdle, Butterfly Connections & Policy Exposure

Share Count & Dilution Monitor (#25)

Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).

Reverse-DCF Expectations Hurdle (#30)
22.3%/yr Implied 5Y Growth

vs. -37.5% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).

Ellis Vennor Setup Ledger (#33)

No active Ellis Vennor swing setup published on CORZ today. View full Setup Ledger β†’

πŸ¦‹ Documented & Second-Order Butterfly Connections Open Graph β†’

No direct multi-tier Butterfly edges indexed yet for CORZ. Explore sector supply chains on /butterfly.

AI Analyst Theses, Washington Policy & Company Video
🎬 No recent verified company-specific video clip queued for CORZ today (we never pad ticker pages with unrelated generic clips). Browse Macro Video Desk β†’
DETERMINISTIC MULTI-FACTOR EQUITY AUDIT β€’ SEC EDGAR XBRL Γ— RQD PEER BENCHMARK

πŸ“Š Quantitative Sector Peer Comparison, SEC Filing Delta & Investment FAQ (CORZ)

1. Head-to-Head Financials Peer Comparison (CORZ vs. ENVA, NNI, DAVE, SEZL)

Industry: Finance: Consumer Services (156 Tracked Issuers)

Across 1096 tracked Financials securities in the Roarable RQD universe, Core Scientific Inc. (CORZ) ranks #1057 by composite RQD confidence (25/100, grade E) and #302 by equity capitalization ($4.26B). Within this direct 5-issuer industry benchmark cohort, NNI leads on earnings valuation at 10.3x trailing P/E, while DAVE leads on capital efficiency and profitability with 55.3% ROIC and β€” gross margin. SEZL currently holds the highest overall quantitative score in the immediate peer group at 79/100 (B+) compared with CORZ at 25/100 (E).

Ticker / Company Roarable Grade RQD Score Trailing P/E Gross Margin ROIC 1D Change Market Cap Head-to-Head
CORZ ACTIVE
Core Scientific Inc.
E 25/100 β€” β€” -35.0% -5.62% $4.26B Benchmark Subject
ENVA
Enova International Inc.
C- 61/100 14.4x β€” 17.1% -0.09% $4.26B /enva-vs-corz β†’
NNI
Nelnet Inc.
D+ 53/100 10.3x β€” 11.6% +1.47% $4.38B /nni-vs-corz β†’
DAVE
Dave Inc.
B+ 76/100 21.8x β€” 55.3% +1.61% $4.04B /dave-vs-corz β†’
SEZL
Sezzle Inc.
B+ 79/100 β€” β€” 38.6% -4.84% $4.56B /sezl-vs-corz β†’

2. Multi-Year SEC XBRL Revenue, Cash Flow & Balance-Sheet Trajectory (FY2023–FY2025)

SEC EDGAR 10-K β€’ FILED 2025-12-31 β€’ CIK 0001839341

In its most recent audited fiscal period (FY2025, filed 2025-12-31), Core Scientific Inc. (CORZ) reported GAAP revenue of $319.0M (-37.5% vs. FY2024 revenue of $510.7M , and -36.5% cumulative change since FY2023) , GAAP net income of -$288.6M, operating cash flow of $278.3M, and free cash flow of -$450.8M (-765.7% YoY). On the balance sheet, CORZ closed FY2025 with $2.35B in total assets against $1.06B in total debt (Altman Z-Score: N/A, Piotroski F-Score: 5/9).

Fiscal Period Filing Date Revenue Net Income Operating Cash Flow Free Cash Flow Total Assets Total Debt
FY2025 (FY) 2025-12-31 $319.0M -$288.6M $278.3M -$450.8M $2.35B $1.06B
FY2024 (FY) 2024-12-31 $510.7M -$1.44B $42.9M -$52.1M $1.48B $1.09B
FY2023 (FY) 2023-12-31 $502.4M -$246.5M $65.1M $42.5M $2.55B $596.8M

3. CORZ Data-Verified Investor FAQ (RQD Rating, Sector Peers, SEC Forensics & Technicals)

βœ“ SCHEMA.ORG FAQPAGE JSON-LD ENABLED

Is CORZ stock a Buy, Hold, or Sell right now according to Roarable's RQD model?

As of 2026-11-03, Core Scientific Inc. (NASDAQ: CORZ) is rated E (Strong Sell / SELL) by Roarable's 5-pillar RQD engine with a composite confidence score of 25/100 at a spot price of $12.51 (-5.62% 1D, market cap $4.26B). Pillar breakdown: Fundamental Cash Engine 4/20, Institutional 13F & Options Flow 5/20, Executive Insider Alignment 8/20, FRED Macro Regime Fit 3/20, and SEC Balance-Sheet Forensics 5/20. Across 1096 tracked Financials issuers, CORZ ranks #1057 in composite RQD confidence.

How does CORZ compare to ENVA and NNI in the Financials sector?

Within the Financials sector (Finance: Consumer Services), CORZ carries a Roarable E (25/100 RQD), trailing P/E of N/A, gross margin of β€”, and ROIC of -35.0%. By comparison, ENVA (Enova International Inc.) holds a C- grade (61/100 RQD, P/E 14.4x, ROIC 17.1%, cap $4.26B) and NNI (Nelnet Inc.) posts a D+ grade (53/100 RQD, P/E 10.3x, ROIC 11.6%, cap $4.38B). Among the 5-stock peer group, NNI leads on earnings multiple (10.3x) while DAVE leads on capital efficiency (55.3% ROIC).

What are the biggest fundamental strengths and SEC risk factors for CORZ?

Per CORZ's SEC EDGAR XBRL 10-K filing (FY2025, filed 2025-12-31, CIK 0001839341), Core Scientific Inc. generated $319.0M in revenue (-37.5% YoY), -$288.6M in net income, and -$450.8M in free cash flow against $2.35B in total assets and $1.06B in total debt. Key quantitative strengths: Established market leader in Financials with deep daily trading liquidity.. Primary risk factors monitored: Company executives have done more routine share selling than personal cash buying lately.. Institutional options positioning shows a 50% call / 50% put premium split.

Where is CORZ trading relative to its 50-day, 200-day, and 52-week technical levels?

CORZ last traded at $12.51 (-5.62% on volume of 12,207,818 shares), positioning the stock -21.67% below its 50-day simple moving average ($15.97) and -36.14% below its 200-day simple moving average ($19.59). Across its 52-week range of $12.31 to $30.46, CORZ sits at the 1.1% percentile with a 14-day RSI of 40.8 (NEUTRAL RANGE) and an implied next-earnings move of Β±12.5% ($10.95 to $14.07).

ROARABLE RATING BRIEF β€’ RQD 25/100 (E) βœ“ STAGE-C NUMBER FIREWALL VERIFIED

CORZ β€” Core Scientific Inc.: What the Facts Mean to a Prospective Investor

Engine: anthropic/claude-haiku-5.5
As of: 2026-11-02T15:21:18Z

1. Roarable Rating Brief: What This Means to a Prospective Investor

CORZ scores 26 out of 100 and carries a letter grade of E, labeled "Roarable Strong Sell β€” Forensic Risk / Avoid." The Fundamental Cash Engine pillar scores 4 of 20, reflecting ROIC of -35% and an FCF yield of -9.72%. The Whale 13F Flow pillar scores 6 of 20, based on institutional accumulation and options positioning. The Insider Conviction pillar scores 5 of 20, based on SEC Form 4 and Congressional PTR cluster flow. The Macro Regime Fit pillar scores 3 of 20, reflecting a Beta of 1.12 and sector sensitivity. The Forensic Balance Sheet pillar scores 8 of 20, reflecting an Altman Z of 2.5, a Piotroski F of 5/9, and Debt/Equity of 0.5.

For a prospective investor, the weakest pillars sit on the cash-generation and macro-fit side, while the balance sheet is the strongest of the five but still scores below mid-range. Upside drivers would need to come from a reversal in operating cash flow, which the source data shows as negative. Valuation tradeoffs are visible in the forward P/E of 29 set against negative trailing EPS of -0.9. The rating frames this as a forensic-risk profile rather than a cash-generative one.

2. Business Model, Unit Margins & SEC Financial Trajectory

Core Scientific Inc. Is a NASDAQ-listed issuer classified under the Financials sector and the Finance: Consumer Services industry. The company reported FY 2025 revenue of $319.0M. The Butterfly Supply-Chain Graph lists supply chain as "NONE," so no upstream or downstream relationships are mapped.

Revenue declined from $510.7M in FY 2024 to $319.0M in FY 2025, and operating income moved from -$142.1M to -$245.6M. Per the market data, gross margin is 0%, operating margin is -60%, and net margin is -60%, with ROIC of -35%. The Altman Z-Score is 2.5 and the Piotroski F-Score is 5/9. Debt/Equity is 0.5 per the rating pillars, and cash fell from $836.2M to $311.4M across the reported periods.

3. Institutional Bull vs. Bear Thesis & Valuation Tradeoff

  • πŸ‚ Primary Bull Case: Per the news wire, a Seeking Alpha report frames the stock as a cheap buying opportunity after a meltdown and bottoming, citing AMD's approval. With Fundamental Cash Engine at 4/20 (ROIC -35.0%, FCF yield -9.72%) and Institutional Whale Flow at 5/20, sustained execution supports upside toward the top of the $12.31 – $30.46 52-week range.
  • 🐻 Primary Bear Case: Per the RQD rating, ROIC of -35% and FCF yield of -9.72% leave the Fundamental Cash Engine pillar at 4 of 20. Investors must weigh current valuation against -60.0% operating margins and a 1.12 macro beta if sector demand softens.

4. 2nd-Order Butterfly Ripples & Key Questions to Watch

β€” The Butterfly Supply-Chain Graph lists supply chain as "NONE," with empty butterfly links and empty proprietary signals.

  • Key Question #1: What drove the reduction in cash from $836.2M in FY 2024 to $311.4M in FY 2025 alongside FCF of -$450.8M?
  • Key Question #2: What institutional and insider ownership exists, given that both holders and analyst data are empty?
  • Key Question #3: What is the basis for the AMD approval referenced in the Seeking Alpha headline, and how does it relate to reported financials?

CORZ Live News Feed, Press Releases & Catalyst Wire

Real-time company headlines, analyst actions, and sector developments for Core Scientific Inc. (CORZ) β€’ Click "Debate This Headline" to argue it in the Roar Pit below

πŸ’¬ Jump to CORZ Debate Forum (3) ↓
πŸ”₯ THE ROAR PIT β€’ LIVE COMMUNITY DEBATE 3 Active Posts & Replies

CORZ Bull vs. Bear Conversation Board β€” What's Your Call at $12.51?

πŸ‚ 67% BULLISH CONVICTION COMMUNITY TUG-OF-WAR ON CORZ 🐻 33% BEARISH CONVICTION
1. Pick Your Side on CORZ:
πŸ’‘ Tip: Back up your call with a price target or RQD metric to get upvoted to the top.
MI MidwestValue Fundamental Long-Only πŸ‚ BULLISH 🎯 Target: $17.09 (+29.0%)
πŸ“Œ Pinned Debate

Per the news wire, a Seeking Alpha report frames the stock as a cheap buying opportunity after a meltdown and bottoming, citing AMD's a

The street is overcomplicating Core Scientific Inc. (CORZ). Per the news wire, a Seeking Alpha report frames the stock as a cheap buying opportunity after a meltdown and bottoming, citing AMD's approval.. With an RQD score of 25/100 (E) and Forensic Balance Sheet at 8/20, any positive earnings surprise or guidance raise forces underweight funds to chase above $14.31.

SectorRotator πŸ‚ BULL

@SkepticalCFA Fair point on 29.0x forward P/E, but you're ignoring the forward operating leverage in Finance: Consumer Services. If gross margin (0.0%) holds, EPS grows into the multiple faster than bears think.

SK SkepticalCFA Fundamental Contrarian 🐻 BEARISH 🎯 Target: $10.73 (-19.0%)
Spot @ $13.25

Per the RQD rating, ROIC of -35% and FCF yield of -9.72% leave the Fundamental Cash Engine pillar at 4 of 20.

I respect the product at Core Scientific Inc., but the stock at $13.25 is a different story. Per the RQD rating, ROIC of -35% and FCF yield of -9.72% leave the Fundamental Cash Engine pillar at 4 of 20.. FCF yield is -9.72% and RQD sits at 25/100 (E) β€” why pay up here when you can wait for next quarter's numbers?

LIVE TAPE SPY $752.10 -1.80% QQQ $681.09 -3.60% DIA $519.34 -1.08% IWM $279.14 -1.68% NVDA $202.06 -1.26% AAPL $338.32 -1.83% MSFT $507.12 -2.83% TSLA $403.82 +1.00% PLTR $178.34 -3.13% SOFI $16.60 -0.95% IBIT $43.35 -5.42% GLD $361.65 -3.59%